Jørn Bolstad Christensen

Jørn Bolstad Christensen serves as an Associate Professor in the Department of Chemistry at the University of Copenhagen, Denmark, with research spanning dendrimer chemistry, nanomedicine, and pharmaceutical applications. His work addresses critical drug delivery challenges including mucosal barriers, antimicrobial resistance, and targeted release systems, supported by over 180 research outputs across journals, books, and patents.

Christensen's research centers on dendrimers and nanocarriers for biomedical applications, with emphasis on antimicrobial agents (e.g., phenothiazine derivatives), photodynamic therapy (e.g., phthalocyanine-cored dendrimers), and oral drug delivery systems. Recent projects investigate polymeric micelle-mucin interactions, pH-sensitive polymersomes for immunosuppressant delivery, and structure-toxicity relationships in PAMAM dendrimers, highlighting interdisciplinary approaches combining synthetic chemistry and biological evaluation.

His publication trends (2023-2025) reveal strong focus on overcoming biological barriers through nanotechnology, particularly for antimicrobial and neurological applications. Work frequently involves computational modeling alongside experimental validation, with emphasis on stereochemistry, carrier geometry, and surface functionalization to optimize efficacy and reduce toxicity.

Christensen actively contributes to academic discourse through lectures on dendrimer applications and antimicrobial research, including presentations at international conferences. He serves on review committees and performs peer review, demonstrating commitment to scholarly service and student supervision as evidenced by co-examiner roles.

Media recognition includes coverage of patented resistance solutions (2016) and dendrimer applications in biotechnology (2008), reflecting translational impact of his research in pharmaceutical sciences.